Leadership
Paramverse Group has appointed Sushree Mishra as Chief of Strategy, Enterprise Initiatives & Execution. In her new role, she will lead corporate strategy, institutional initiatives and execution priorities, working closely with the Founder’s Office to support the Group’s expansion across biotechnology, artificial intelligence and technology-led businesses.
Sushree brings around a decade of leadership experience across pharmaceuticals and private equity-backed business transformation. Before joining Paramverse Group, she spent over five years at JB Pharma, a KKR portfolio company, as Head of Global Corporate Strategy, Communications & In-Licensing.
During her career, she has also led multiple award-winning initiatives at JB Pharma and Cipla, bringing experience in strategic planning, corporate communications and business development.
At Paramverse Group, her mandate will include supporting the institutional scale-up of its biotechnology platform, Paramverse Bio, across biological agriculture, pharmaceutical contract development and manufacturing, specialty enzymes and bio-actives. She will also contribute to evaluating and operationalising new business opportunities across the Group.
Sushree is an alumna of Harvard Business School.
CXO TechBOT congratulates Sushree on her appointment and wishes her continued success in her new leadership role.